Lactobacillus reuteri and Escherichia coli in the human gut microbiota may predict weight gain associated with vancomycin treatment

Nutrition and Diabetes

Volumn 3, Issue SEPTEMBER, 2013, Pages

  Million, M ^a   Thuny, F ^a,b,c   Angelakis, E ^a   Casalta, J P ^b   Giorgi, R ^a   Habib, G ^b   Raoult, D ^a,b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b TIMONE HOSPITAL   (France)

^c HÔPITAL NORD   (France)

Author keywords

Antibiotics; Escherichia coli; Gut microbiota; Lactobacillus; Obesity

Indexed keywords

GENTAMICIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; BACTEROIDETES; BIFIDOBACTERIUM ANIMALIS; BODY MASS; CONTROLLED STUDY; ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; FIRMICUTES; HUMAN; INTESTINE FLORA; LACTOBACILLUS PLANTARUM; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; MAJOR CLINICAL STUDY; MALE; METHANOBREVIBACTER SMITHII; OBESITY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIDE EFFECT; TREATMENT DURATION; WEIGHT CHANGE; WEIGHT GAIN;

EID: 84886695993     PISSN: None     EISSN: 20444052     Source Type: Journal    
DOI: 10.1038/nutd.2013.28     Document Type: Article

References (55)

1. Stokstad EL, Jukes TH. The multiple nature of the animal protein factor. J Biol Chem 1949; 180: 647-654.
2. Summary report on antimicrobials sold or distributed for use in food-producing animals. Food and drug administration, 2009.
3. Antibiotic resistance back in the news. Animal Health Institute (USA). AHI quaterly 1998; 19: 1-4.
4. Haight TH, Pierce WE. Effect of prolonged antibiotic administration of the weight of healthy young males. J Nutr 1955; 56: 151-161.
5. Ozawa E. Studies on growth promotion by antibiotics. II. Results of aurofac administration to infants. J Antibiot 1955; 8: 212-214.
6. Robinson P. Controlled trial of aureomycin in premature twins and triplets. Lancet 1952; 259: 52.
7. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444: 1022-1023.
8. Trehan I, Goldbach HS, LaGrone LN, Meuli GJ, Wang RJ, Maleta KM et al. Antibiotics as part of the management of severe acute malnutrition. N Engl J Med 2013; 368: 425-435.
9. Smith MI, Yatsunenko T, Manary MJ, Trehan I, Mkakosya R, Cheng J et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science 2013; 339: 548-554.
10. Feighner SD, Dashkevicz MP. Subtherapeutic levels of antibiotics in poultry feeds and their effects on weight gain, feed efficiency, and bacterial cholyltaurine hydrolase activity. Appl Environ Microbiol 1987; 53: 331-336.
11. Thuny F, Richet H, Casalta JP, Angelakis E, Habib G, Raoult D. Vancomycin treatment of infective endocarditis is linked with recently acquired obesity. PLoS One 2010; 5: e9074.
12. Cho I, Yamanishi S, Cox L, Methe BA, Zavadil J, Li K et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 2012; 488: 621-626.
13. Million M, Angelakis E, Maraninchi M, Henry M, Giorgi R, Valero R et al. Correlation between body mass index and gut concentrations of Lactobacillus reuteri, Bifidobacterium animalis, Methanobrevibacter smithii and Escherichia coli. Int J Obes 2013; e-pub ahead of print 5 March 2013; doi:10.1038/ijo.2013. 20.
14. Million M, Maraninchi M, Henry M, Armougom F, Richet H, Carrieri P et al. Obesityassociated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. Int J Obes (Lond) 2012; 36: 817-825.
15. Li JS, Sexton DJ, Mick N, Nettles R, Fowler Jr VG, Ryan T et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30: 633-638.
16. Botelho-Nevers E, Thuny F, Casalta JP, Richet H, Gouriet F, Collart F et al. Dramatic reduction in infective endocarditis-related mortality with a management-based approach. Arch Intern Med 2009; 169: 1290-1298.
17. Schwiertz A, Taras D, Schafer K, Beijer S, Bos NA, Donus C et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 2010; 18: 190-195.
18. Dridi B, Henry M, El KA, Raoult D, Drancourt M. High prevalence of Methanobrevibacter smithii and Methanosphaera stadtmanae detected in the human gut using an improved DNA detection protocol. PLoS One 2009; 4: e7063.
19. Armougom F, Henry M, Vialettes B, Raccah D, Raoult D. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients. PLoS One 2009; 4: e7125.
20. Barnard GA. A New test for 2×2 tables. Nature 1945; 156: 783-784.
21. Karlsson FH, Tremaroli V, Nookaew I, Bergstrom G, Behre CJ, Fagerberg B et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 2013; 498: 99-103.
22. Trasande L, Blustein J, Liu M, Corwin E, Cox LM, Blaser MJ. Infant antibiotic exposures and early-life body mass. Int J Obes 2012; 37: 16-23.
23. Ajslev TA, Andersen CS, Gamborg M, Sorensen TI, Jess T. Childhood overweight after establishment of the gut microbiota: the role of delivery mode, prepregnancy weight and early administration of antibiotics. Int J Obes 2011; 35: 522-529.
24. Million M, Raoult D. The role of the manipulation of the gut microbiota in obesity. Curr Infect Dis Rep 2013; 15: 25-30.
25. Lev M, Forbes M. Growth response to dietary penicillin of germ-free chicks and of chicks with a defined intestinal flora. Br J Nutr 1959; 13: 78-84.
26. Cole Jr. JR, Boyd FM. Fat absorption from the small intestine of gnotobiotic chicks. Appl Microbiol 1967; 15: 1229-1234.
27. Million M, Angelakis E, Paul M, Armougom F, Leibovici L, Raoult D. Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals. Microb Pathog 2012; 53: 100-108.
28. Stsepetova J, Sepp E, Kolk H, Loivukene K, Songisepp E, Mikelsaar M. Diversity and metabolic impact of intestinal Lactobacillus species in healthy adults and the elderly. Br J Nutr 2011; 105: 1235-1244.
29. Fak F, Backhed F. Lactobacillus reuteri prevents diet-induced obesity, but not atherosclerosis, in a strain dependent fashion in Apoe-/- mice. PLoS One 2012; 7: e46837.
30. Million M, Raoult D. Species and strain specificity of Lactobacillus probiotics effect on weight regulation. Microb Pathog 2013; 55: 52-54.
31. Jacobsen CN, Rosenfeldt N,V, Hayford AE, Moller PL, Michaelsen KF, Paerregaard A et al. Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl Environ Microbiol 1999; 65: 4949-4956.
32. Dubray C, Ibrahim SA, Abdelmutalib M, Guerin PJ, Dantoine F, Belanger F et al. Treatment of severe malnutrition with 2-day intramuscular ceftriaxone vs 5-day amoxicillin. Ann Trop Paediatr 2008; 28: 13-22.
33. Zhang L, Huang Y, Zhou Y, Buckley T, Wang HH. Antibiotic administration routes significantly influence the levels of antibiotic resistance in gut microbiota. Antimicrob Agents Chemother 2013; 57: 3659-3666.
34. Fouhy F, Guinane CM, Hussey S, Wall R, Ryan CA, Dempsey EM et al. High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin. Antimicrob Agents Chemother 2012; 56: 5811-5820.
35. Turnbaugh PJ, Quince C, Faith JJ, McHardy AC, Yatsunenko T, Niazi F et al. Organismal, genetic, and transcriptional variation in the deeply sequenced gut microbiomes of identical twins. Proc Natl Acad Sci USA 2010; 107: 7503-7508.
36. Dubos R, Schaedler RW, Costello RL. The effect of antibacterial drugs on the weight of mice. J Exp Med 1963; 117: 245-257.
37. Pirzada OM, McGaw J, Taylor CJ, Everard ML. Improved lung function and body mass index associated with long-term use of Macrolide antibiotics. J Cyst Fibros 2003; 2: 69-71.
38. Saiman L, Mayer-Hamblett N, Anstead M, Lands LC, Kloster M, Goss CH et al. Open-label, follow-on study of azithromycin in pediatric patients with CF uninfected with Pseudomonas aeruginosa. Pediatr Pulmonol 2012; 47: 641-648.
39. Clement A, Tamalet A, Leroux E, Ravilly S, Fauroux B, Jais JP. Long term effects of azithromycin in patients with cystic fibrosis: a double blind, placebo controlled trial. Thorax 2006; 61: 895-902.
40. Mansi Y, Abdelaziz N, Ezzeldin Z, Ibrahim R. Randomized controlled trial of a high dose of oral erythromycin for the treatment of feeding intolerance in preterm infants. Neonatology 2011; 100: 290-294.
41. Lane JA, Murray LJ, Harvey IM, Donovan JL, Nair P, Harvey RF. Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study. Aliment Pharmacol Ther 2011; 33/8: 922-929.
42. Kamada T, Hata J, Kusunoki H, Ito M, Tanaka S, Kawamura Y et al. Eradication of Helicobacter pylori increases the incidence of hyperlipidaemia and obesity in peptic ulcer patients. Dig Liver Dis 2005; 37: 39-43.
43. Patterson PR. Minocycline in the antibiotic regimen of cystic fibrosis patients: weight gain and clinical improvement. Clin Pediatr 1977; 16: 60-63.
44. Edlund C, Barkholt L, Olsson-Liljequist B, Nord CE. Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy. Clin Infect Dis 1997; 25: 729-732.
45. Lund B, Edlund C, Barkholt L, Nord CE, Tvede M, Poulsen RL. Impact on human intestinal microflora of an Enterococcus faecium probiotic and vancomycin. Scand J Infect Dis 2000; 32: 627-632.
46. Van der Auwera P, Pensart N, Korten V, Murray BE, Leclercq R. Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. J Infect Dis 1996; 173: 1129-1136.
47. Robinson CJ, Young VB. Antibiotic administration alters the community structure of the gastrointestinal micobiota. Gut Microbes 2010; 1: 279-284.
48. Yap IK, Li JV, Saric J, Martin FP, Davies H, Wang Y et al. Metabonomic and microbiological analysis of the dynamic effect of vancomycin-induced gut microbiota modification in the mouse. J Proteome Res 2008; 7: 3718-3728.
49. Swedish Study Group. A randomized multicenter trial to compare the influence of cefaclor and amoxycillin on the colonization resistance of the digestive tract in patients with lower respiratory tract infection. Infection 1991; 19: 208-215.
50. Brismar B, Edlund C, Nord CE. Impact of cefpodoxime proxetil and amoxicillin on the normal oral and intestinal microflora. Eur J Clin Microbiol Infect Dis 1993; 12: 714-719.
51. Floor M, van AF, Rozenberg-Arska M, Visser M, Kolsters A, Beumer H et al. Effect of loracarbef and amoxicillin on the oropharyngeal and intestinal microflora of patients with bronchitis. Scand J Infect Dis 1994; 26: 191-197.
52. Stark CA, Adamsson I, Edlund C, Sjosted S, Seensalu R, Wikstrom B et al. Effects of omeprazole and amoxycillin on the human oral and gastrointestinal microflora in patients with Helicobacter pylori infection. J Antimicrob Chemother 1996; 38: 927-939.
53. Schumann A, Nutten S, Donnicola D, Comelli EM, Mansourian R, Cherbut C et al. Neonatal antibiotic treatment alters gastrointestinal tract developmental gene expression and intestinal barrier transcriptome. Physiol Genomics 2005; 23: 235-245.
54. Million M, Lagier JC, Yahav D, Paul M. Gut bacterial microbiota and obesity. Clin Microbiol Infect 2013; 19: 305-313.
55. Markle JG, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 2013; 339: 1084-1088.